Gilead’s Remdesivir Becomes First Virus Treatment to Win FDA Nod
Signage is displayed outside Gilead Sciences Inc. headquarters in Foster City, California, U.S.  (Photographer: David Paul Morris/Bloomberg)

Gilead’s Remdesivir Becomes First Virus Treatment to Win FDA Nod

(Bloomberg) -- The U.S. Food and Drug Administration approved Gilead Sciences Inc.’s antiviral therapy remdesivir on Thursday, making it the first drug to obtain formal clearance for treating the c...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.